Recent data suggests that 60% of providers know little

to nothing about monoclonal antibody treatment

Monoclonal antibody (mAb) therapy is proven to be effective at shortening symptom duration by an average of four days, and preventing severe illness, hospitalization, and death from COVID for ambulatory patients at high risk of progression to serious disease. In a survey of Coloradans, 96 percent of people surveyed said they would consider mAb treatment if a provider recommended it. Despite the proven effectiveness of mAb therapy, questions about efficacy, administration, access, talking to patients, and more prevent health care providers from maximizing the use of mAb treatment. This 90-minute webinar—a statewide collaboration led by the Colorado Department of Public Health & Environment—offers concise, actionable information followed by a live Q&A with clinical and implementation experts. 

The webinar will cover data around current mAb use in Colorado, a brief overview of how mAbs work and the use of mAbs in viral infections, clinical data supporting efficacy for use with COVID, clinical pathways/guidelines, essential logistics (infusion v. subQ, monitoring, adverse reactions, cost, insurance issues, how to communicate with patients), resources for further questions, and the webinar will end with an expert panel Q&A.

A Provider’s Guide to Monoclonal Antibody Therapy for COVID-19 Webinar

Colorado health care providers (MD, DO, APP, RN, etc.) and administrators interested in monoclonal antibody therapy for COVID-19 patients in the ambulatory setting

This ECHO Colorado series is co-sponsored by the Colorado Academy of Family Physicians. It has been reviewed and found acceptable for 1.5 credits by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity (1.5 credits for one session).

Three sessions offered. Choose one:

Tuesday, August 24, 12:00 - 1:30 PM MT

Wednesday, August 25, 7:00 - 8:30 AM MT

Monday, August 30, 7:00 - 8:30 AM MT

In Partnership With:

Colorado Department of Public Health & Environment

mAb Colorado project/Colorado Clinical & Translational Sciences Institute at the University of Colorado Anschutz Medical Campus

Denver Health